Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure.
Jean-Jacques StelmesE VuV GrégoireC SimonE ClementelJ KazmierskaW GrantM OzsahinM TomsejL VieillevigneC FortpiedE C HurkmansA BranquinhoN AndratschkeF ZimmermannD-C WeberPublished in: Radiation oncology (London, England) (2021)
This is to our knowledge the largest BC analysis among Head and neck RTQA programs performed in the framework of a prospective trial. Benchmarking identified non-common OARs and target delineations errors as the main source of deviations and IOV could be reduced in a significant number of cases after this process. Due to the substantial resources involved with benchmarking, future benchmark analyses should assess fully the impact on patients' clinical outcome.
Keyphrases
- early stage
- end stage renal disease
- study protocol
- newly diagnosed
- phase iii
- clinical trial
- ejection fraction
- chronic kidney disease
- healthcare
- phase ii
- randomized controlled trial
- public health
- patient safety
- peritoneal dialysis
- radiation therapy
- prognostic factors
- squamous cell carcinoma
- patient reported outcomes
- current status
- lymph node
- sentinel lymph node
- data analysis
- placebo controlled